Data / Form D filings / Panome Bio Inc.
Panome Bio Inc.: Form D filings
Panome Bio Inc., a biotechnology company in Saint Louis, MO, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on November 21, 2024, reports $6 million sold of a $6 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4340 DUNCAN AVENUE, Saint Louis, MO, 63110
- Phone
- (314) 477-4334
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966691
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | New notice | $6,000,000 | $6,000,000 | 6 | Nov 14, 2024 | sec.gov | |
| Feb 24, 2023 | New notice | $5,973,835 | $5,973,835 | 6 | Feb 15, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Smoller | Director | |
| Tom Cohen | Executive Officer | |
| Rob Capone | Director | |
| Edward Weinstein | Executive Officer, Director | |
| Deval Lashkari | Director |
Every Form D from the week of Nov 18, 2024 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Panome Bio Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.